Joe T.R. Clarke

6.4k total citations
84 papers, 4.5k citations indexed

About

Joe T.R. Clarke is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Joe T.R. Clarke has authored 84 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Physiology, 27 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Joe T.R. Clarke's work include Lysosomal Storage Disorders Research (45 papers), Metabolism and Genetic Disorders (16 papers) and Trypanosoma species research and implications (16 papers). Joe T.R. Clarke is often cited by papers focused on Lysosomal Storage Disorders Research (45 papers), Metabolism and Genetic Disorders (16 papers) and Trypanosoma species research and implications (16 papers). Joe T.R. Clarke collaborates with scholars based in Canada, United States and United Kingdom. Joe T.R. Clarke's co-authors include Michael Beck, Don J. Mahuran, Michael B. Tropak, Roberto Giugliani, John Christodoulou, Gustavo Maegawa, Marianne Rohrbach, Raphael Schiffmann, Bibudhendra Sarkar and Tracy Stockley and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Joe T.R. Clarke

83 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joe T.R. Clarke Canada 38 2.6k 1.5k 1.1k 718 696 84 4.5k
Ben J. H. M. Poorthuis Netherlands 36 3.2k 1.2× 1.5k 1.0× 1.6k 1.4× 1.0k 1.4× 530 0.8× 61 4.8k
C. Ronald Scott United States 36 2.2k 0.9× 931 0.6× 856 0.8× 479 0.7× 826 1.2× 81 4.7k
Rossella Parini Italy 38 3.1k 1.2× 1.5k 1.0× 1.3k 1.2× 580 0.8× 832 1.2× 179 5.1k
Joe T.R. Clarke Canada 32 1.5k 0.6× 1.1k 0.8× 524 0.5× 584 0.8× 537 0.8× 109 2.8k
Vassili Valayannopoulos France 39 2.0k 0.8× 1.5k 1.0× 834 0.8× 412 0.6× 1.4k 2.1× 125 4.7k
Olaf A. Bodamer United States 34 1.9k 0.7× 1.4k 0.9× 701 0.6× 643 0.9× 1.0k 1.4× 156 4.2k
Seymour Packman United States 44 2.1k 0.8× 2.6k 1.7× 854 0.8× 991 1.4× 1.2k 1.8× 135 6.5k
Sarah P. Young United States 35 2.1k 0.8× 1.2k 0.8× 744 0.7× 447 0.6× 388 0.6× 105 3.8k
Alessandro P. Burlina Italy 33 1.9k 0.7× 1.1k 0.7× 657 0.6× 470 0.7× 823 1.2× 113 3.3k
Hanna Mandel Israel 43 1.8k 0.7× 4.0k 2.6× 545 0.5× 534 0.7× 2.4k 3.5× 176 7.4k

Countries citing papers authored by Joe T.R. Clarke

Since Specialization
Citations

This map shows the geographic impact of Joe T.R. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe T.R. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe T.R. Clarke more than expected).

Fields of papers citing papers by Joe T.R. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe T.R. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe T.R. Clarke. The network helps show where Joe T.R. Clarke may publish in the future.

Co-authorship network of co-authors of Joe T.R. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Joe T.R. Clarke. A scholar is included among the top collaborators of Joe T.R. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe T.R. Clarke. Joe T.R. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Christel, Jaina Patel, Eva Mamak, et al.. (2017). Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study. European Journal of Paediatric Neurology. 21(4). 600–609. 21 indexed citations
2.
Smyth, Bruce, Paul Marsden, Ryan B. Corcoran, et al.. (2016). Opportunistic screening for atrial fibrillation in a rural area. QJM. 109(8). 539–543. 20 indexed citations
3.
Schiffmann, Raphael, Markus Ries, Derek Blankenship, et al.. (2013). Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa. Genetics in Medicine. 15(12). 983–989. 24 indexed citations
4.
Winquist, Eric, Chaim M. Bell, Joe T.R. Clarke, et al.. (2012). An Evaluation Framework for Funding Drugs for Rare Diseases. Value in Health. 15(6). 982–986. 41 indexed citations
5.
Waldek, Stephen, Edward H. Giannini, Atul Mehta, et al.. (2010). 140. A validated disease severity scoring system for Fabry disease. Molecular Genetics and Metabolism. 99(2). S37–S37. 4 indexed citations
6.
Clarke, Joe T.R., et al.. (2010). Case report: long‐term outcome post‐heart transplantation in a woman with Fabry's disease. Journal of Inherited Metabolic Disease. 33(S3). 385–387. 8 indexed citations
7.
Schiffmann, Raphael, Rick A. Martin, Tyler Reimschisel, et al.. (2010). Four-Year Prospective Clinical Trial of Agalsidase Alfa in Children with Fabry Disease. The Journal of Pediatrics. 156(5). 832–837.e1. 49 indexed citations
8.
Maegawa, Gustavo, Gustavo Maegawa, Benjamin Schmitt, et al.. (2010). 88. Brain MRS in patients with juvenile GM2 gangliosidosis receiving substrate reduction therapy. Molecular Genetics and Metabolism. 99(2). S26–S26. 1 indexed citations
9.
Schwartz, Ida Vanessa Döederlein, Osvaldo Artigalás, Markus Ries, et al.. (2009). Punctate calcifications in lysosomal storage disorders. Clinical Dysmorphology. 18(3). 172–177. 1 indexed citations
10.
West, Michael L., Kathy Nicholls, Atul Mehta, et al.. (2009). Agalsidase Alfa and Kidney Dysfunction in Fabry Disease. Journal of the American Society of Nephrology. 20(5). 1132–1139. 119 indexed citations
11.
Mehta, Atul, Michael Beck, Perry Elliott, et al.. (2009). Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. The Lancet. 374(9706). 1986–1996. 208 indexed citations
12.
Maegawa, Gustavo, Michael B. Tropak, Tracy Stockley, et al.. (2007). Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis. Journal of Biological Chemistry. 282(12). 9150–9161. 133 indexed citations
13.
Oudit, Gavin Y., Jagdish Butany, William G. Williams, Joe T.R. Clarke, & Robert M. Iwanochko. (2007). Left Ventricular Aneurysm Associated With Mucopolysaccharidosis Type VI Syndrome (Maroteaux–Lamy Syndrome). Circulation. 115(5). e60–2. 8 indexed citations
14.
Oudit, Gavin Y., Jagdish Butany, William G. Williams, et al.. (2007). Left ventricular aneurysm in a patient with mucopolysaccharidosis type VI (Maroteaux–Lamy syndrome): clinical and pathological correlation. Cardiovascular Pathology. 16(4). 237–240. 15 indexed citations
15.
Inoue, Ken, Hitoshi Osaka, Virginia C. Thurston, et al.. (2002). Genomic Rearrangements Resulting in PLP1 Deletion Occur by Nonhomologous End Joining and Cause Different Dysmyelinating Phenotypes in Males and Females. The American Journal of Human Genetics. 71(4). 838–853. 125 indexed citations
16.
Bagshaw, Richard D., Sunqu Zhang, Marie‐Anne Skomorowski, et al.. (2002). Novel mutations (Asn 484 Lys, Thr 500 Ala, Gly 438 Glu) in Morquio B disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(3). 247–253. 15 indexed citations
17.
Kennedy, Shelley, David Chitayat, Pranesh Chakraborty, et al.. (2002). Clinical and genetic aspects of trigonocephaly: A study of 25 cases. American Journal of Medical Genetics Part A. 117A(2). 127–135. 34 indexed citations
18.
Smith, Mary Lou, et al.. (1998). Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria. Archives of Disease in Childhood. 78(2). 116–121. 30 indexed citations
19.
Clarke, Joe T.R., et al.. (1991). Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.. PubMed. 49(2). 289–97. 39 indexed citations
20.
Arpaia, Enrico, Anne Dumbrille-Ross, Kuldeep Neote, et al.. (1988). Identification of an altered splice site in Ashkenazi Tay-Sachs disease. Nature. 333(6168). 85–86. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026